AuroBlog - Aurous Healthcare Clinical Trials blog

JUNE 2, 2024

The Central Drugs Standard Control Organisation (CDSCO) has released an updated version of the guidance for Post Approval Changes in Biological Products, regarding the quality, safety and efficacy documents in order to align with the updated standards and digital formats developed after the previous version was rolled out. of […]

Production 142

Production Development Drugs Clinical Trials 142

Pharmaceutical Technology

MAY 17, 2024

Galapagos has signed a partnership with Blood Centers of America to expedite decentralised production of CAR-T cell therapies across the US.

Production 130

Production 130

Pharmaceutical Technology

JUNE 5, 2024

Having a competent and efficient partner by your side can elevate your mass production to new levels of efficiency and sustainable success.

Production 130

Production 130

Pharmaceutical Technology

MAY 27, 2024

Reddy's Laboratories' Russian subsidiary and Novartis Pharma signed a deal for the distribution of anti-diabetes products.

Production 130

Production 130

Bio Pharma Dive

JUNE 5, 2024

How can small and mid-sized biotech companies better manage pharmacovigilance during clinical trials? Listen to the podcast to learn how strategic alliances are helping.

Production 318

Production Clinical Trials Clinical Trials Trials 318

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 3, 2024

Evidence does not support the use of cannabidiol (CBD) products as a treatment for chronic pain, a new review found.

Production 197

Production Packaging Packaging Clinical Trials 197

Bio Pharma Dive

MAY 15, 2023

Vetter brings a proven launch management process that combines extensive experience with in-depth product knowledge.

Production 257

Production Drugs 257

Pharmaceutical Technology

JUNE 19, 2023

Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. Laurus Labs will be responsible for launching these products in India and emerging markets.

Gene Therapy 246

Gene Therapy Gene Production Pharma Companies 246

Pharmaceutical Technology

APRIL 13, 2023

The now expanded agreement will enable Rubic to explore other therapeutic avenues in both the human and animal health product markets. The extension of the agreement beyond its original Covid-19 focus will accelerate development timelines, increase productivity, and lower manufacturing costs, according to Dyadic’s CEO Mark Emalfarb.

Production 279

Production Vaccination Vaccine Protein 279

Pharmaceutical Technology

NOVEMBER 1, 2022

FEATURED COMPANIES COMMENDED : • Innovation • Product Launch • Safety VIEW PROFILE COMMENDED : • Business Expansion • Innovation • Investments VIEW PROFILE COMMENDED: • Social VIEW PROFILE. What are Product Launches? The Product Launches category recognises companies that have launched notable new products or services into the market.

Production 130

Production Marketing Manufacturing Vaccination 130

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 9, 2024

India’s export of Ayush and herbal products has reported a growth of 3.6 per cent during the fiscal year 2023-24, at $651.17 million as compared to the same period of previous year, registering a below-five per cent growth for the second consecutive year. The country reported exports of 10.63

Production 141

Production Clinical Trials Clinical Trials Trials 141

Pharmaceutical Technology

FEBRUARY 21, 2024

Contract development and manufacturing organisation Genezen has announced plans to license CSL’s Cytegrity lentivirus production system.

Licensing 130

Licensing Licensing Production Manufacturing 130

Pharmaceutical Technology

MAY 6, 2024

Cipla and Glenmark Pharmaceuticals are recalling specific products from the US market due to distinct manufacturing issues.

Production 130

Production Manufacturing Marketing 130

BioSpace

MAY 29, 2024

In this second episode of our collaboration with DIA, we discuss the challenging, collaborative process of regulating advanced therapy product development with guests James Wabby, AbbVie and Rob Schulz, Suttons Creek, Inc.

Production 109

Production Regulation Development 109

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in rAAV production technology for the pharmaceutical industry.

Gene Therapy 223

Gene Therapy Production Gene 223

World of DTC Marketing

APRIL 5, 2022

The old model of looking at performance in the first six months of product launch isn’t relevant. Today, colossal budget product launches are not returning the same ROI as before. Product launches are going to need to be micro-targeted to specific audiences. What is the definition of a successful pharma product launch?

Production 196

Production Pharma Companies Branding Marketing 196

Bio Pharma Dive

FEBRUARY 19, 2021

The drugmaker will use production lines at its plant in McPherson, Kansas to help fill vaccine vials, company CEO Albert Bourla said Friday.

Production 357

Production Vaccination Vaccine 357

BioSpace

MAY 22, 2024

BioSpace's Lori Ellis discusses the risks and challenges of cell and gene therapy combination products with DIA speakers James Wabby, AbbVie and Rob Schulz, Suttons Creek, Inc.

Production 123

Production Gene Therapy Gene 123

Bio Pharma Dive

APRIL 22, 2024

A partnership with Cellares, worth up to $380 million, is meant to help Bristol Myers speed and scale manufacture of the complex cellular treatments.

Production 296

Production Manufacturing 296

Pharmaceutical Technology

SEPTEMBER 14, 2023

Astellas Pharma is submitting a planning application for the construction of a new drug production facility in Ireland.

Production 173

Production Drugs 173

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 7, 2024

The Central Drugs Standard Control Organisation (CDSCO) has come out with a draft of revised guidance document for the industry related to the quality, safety and efficacy documents for Post Approval Changes (PACs) in biological products in order to align the standards with the international guidelines including that of World Health Organisation (WHO) (..)

Production 187

Production Drugs Clinical Trials Clinical Trials 187

Fierce Pharma

APRIL 18, 2024

Novo Nordisk is receiving pushback from a trio of lawmakers over its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year | Novo Nordisk is receiving pushback from a trio of lawmakers on its decision to discontinue its long-acting insulin product Levemir, which was due for (..)

Insulin 135

Insulin Production 135

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 16, 2024

per cent of India’s Ayush and herbal products during the fiscal year 2023-24. The top 10 destinations led by USA, Germany and Italy accounted for almost 63.3 Exports to these 10 countries together stood at $412 million, with a growth of 5.10 per cent compared to the $392 million exports to top 10 destinations during […]

Production 155

Production Clinical Trials Clinical Trials Clinical Research 155

Pharmaceutical Technology

MAY 23, 2023

Croda Pharma has entered a strategic collaboration deal with Botanical Solution Inc (BSI) to expedite the production of sustainable pharmaceutical-grade vaccine adjuvant QS-21. The plentiful supply of QS-21 enables the production of next-generation adjuvant systems for new vaccine development.”

Production 240

Production Vaccination Vaccine Life Science 240

pharmaphorum

APRIL 8, 2024

Creating a winning playbook for consistent digital product success involves strategic planning, execution, and continuous improvement. Discover key strategies and practices to ensure your digital products achieve lasting success.

Production 111

Production 111

Pharmaceutical Technology

JULY 2, 2024

Teva’s asthma and COPD patents listed in the FDA’s Orange Book are under scrutiny and the company has until 24 July to adhere to the demands.

130

130

Drug Discovery World

MAY 21, 2024

PrimeCap T7 RNA Polymerase is a mutant T7 RNA polymerase that has been genetically engineered to maintain high-performance RNA synthesis activity while reducing dsRNA production to less than 10%. We are thrilled to launch this enzyme which will remove both the technical and financial barriers to the successful production of mRNA therapeutics.”

Production 59

Production RNA In-Vitro Genetic Engineering 59

Fierce Pharma

JUNE 20, 2024

Previously, Baxter was on the hook to pay just $15 million for Samsung’s production assistance. . | The revised deal, first established back in July of 2017, will now see Baxter pay Samsung upwards of $223 million for its manufacturing services through end of 2034.

Production 105

Production Manufacturing Drugs 105

Bio Pharma Dive

SEPTEMBER 18, 2023

As integrated evidence generation takes center stage for driving evidence-based decision making across the product life cycle, automated registries just might be the linchpin that pulls it all together.

Production 150

Production 150

Pharmaceutical Technology

JUNE 27, 2023

Tonix Pharmaceuticals and Tonix Medicines have signed an agreement for the acquisition of Upsher-Smith Laboratories’ two migraine products.

Production 130

Production Medicine 130

Pharmaceutical Technology

DECEMBER 5, 2022

Women’s healthcare company TherapeuticsMD has sign ed agreements for licensing its products to the Mayne Pharma affiliate in the US. TherapeuticsMD will also sell specific assets to Mayne, permitting the latter to market these products, including inventory. Additionally, TherapeuticsMD is entitled to receive another nearly $13.1m

Licensing 130

Licensing Licensing Production Marketing 130

Pharma Mirror

JANUARY 24, 2023

At the core of this trend is replacing outdated legacy manufacturing techniques where cells The post Modernizing Therapeutic Cell Production appeared first on Pharma Mirror Magazine. With so much at stake, attention is now shifting to adopting more modern equipment and methods to consistently produce the best cells.

Production 130

Production Gene Therapy Manufacturing Gene 130

Pharma Mirror

FEBRUARY 6, 2024

In addition to utilizing RWE in clinical research, there is a growing trend toward implementing RWE early in the product development lifecycle. In recent years, European regulators have supported the The post RWE’s Impact on Product Lifecycle for Biopharma Startups appeared first on Pharma Mirror Magazine.

Production 100

Production Packaging Packaging Clinical Research 100

Pharmaceutical Technology

JULY 4, 2023

Tonix Pharmaceuticals and Tonix Medicines have acquired two migraine products from Upsher-Smith Laboratories.

Production 130

Production Medicine 130

Pharmaceutical Technology

AUGUST 9, 2023

GenScript Biotech has expanded the peptide production capabilities at its new life-sciences manufacturing facility located in Zhenjiang.

Production 130

Production Life Science Manufacturing 130